How do you take inositol?

Forms and strengths
TrialDose and schedulePeopleLength
Nordio, 2019Seven formulations (D-chiro-inositol alone and myo-inositol to D-chiro-inositol ratios from 1:3.5 to 80:1), 2 g of inositols twice a day, by mouth1Fifty-six PCOS patients, 8 per group3 months
Benelli, 2016Soft gel capsule of 550 mg myo-inositol, 13.8 mg D-chiro-inositol and 200 micrograms folic acid (40:1), twice a day346 obese women with PCOS: 21 on inositol, 25 on folic acid as placeboSix months
van der Wel, 2025 (JAMA trial)One sachet of 0.2 mg folic acid and 2 g myo-inositol, twice daily2464 pregnant people with PCOS: 230 on inositol, 234 on placebo with 0.2 mg folic acidUntil delivery

In three PCOS trials, inositol was taken by mouth twice a day: 2 g of inositols for 3 months (fifty-six patients), a 2 g myo-inositol sachet with 0.2 mg folic acid until delivery (464 pregnant people), or a soft gel capsule of 550 mg myo-inositol, 13.8 mg D-chiro-inositol and 200 micrograms folic acid for six months (46 women).123

Forms and strengths

The table is set at the top of the page

The one US DailyMed label found for a myo and D-chiro product, Hormon Balance capsules, gives no dose, strength or schedule.4 Maker strengths for retail products could not be sourced, so the figures above are the trials' own.

The van der Wel trial's sachets held a neutral-tasting powder with 2 g of myo-inositol and 0.2 mg of folic acid, and participants were told to take one sachet twice daily, added to food, diluted in water or juice, or consumed directly.5 No volume of water is given, and searches of labels, the FDA letter and maker pages found none.

Doses, ratios and length in trials

A search of DailyMed and the FDA letter found no label or regulator dose for a myo and D-chiro product. The FDA letter relays a notifier's statement that clinical study doses reached 20,000 mg/person/day.6

On ratio, the Nordio authors report 40:1 as best for restoring ovulation, with the other formulations less effective.1 In a 2012 randomised trial by Nordio and Proietti of fifty overweight women with PCOS, the authors gave myo-inositol with D-chiro-inositol or myo-inositol alone for six months, and call 40:1 the physiological plasma ratio.7 A 2025 trial by Gul and colleagues gave 60 women with PCOS either a 40:1 myo-inositol and D-chiro-inositol combination or metformin for 12 weeks, and its paper gives no mg dose.8 Its registry record, NCT05767515, plans inositol isomers at 2000mg BD Daily for 30 infertile women with PCOS, with 120 enrolled and a 6-month time frame, so the paper and the record disagree on size and length.9

In panic disorder, a 1995 crossover trial by Benjamin and colleagues gave 12 g/day of inositol against placebo in 4-week phases to twenty-one patients, and a 2001 crossover trial by Palatnik and colleagues gave inositol up to 18 g/day for 1 month and fluvoxamine up to 150 mg/day for 1 month to twenty patients; in OCD, a 1996 crossover trial by Fux and colleagues gave 18 g/day of inositol or placebo for 6 weeks each to thirteen patients.101112 The searches turned up no trial of inositol doses for anxiety in general.

Is there a cycle schedule?

The Benelli trial states that all its patients were in the follicular phase at the start, but it does not describe cycle-timed dosing.3 A search for trials of cycle-timed inositol dosing returned no records. The Cochrane review of myo-inositol in pregnancy calls for trials comparing myo-inositol at different doses, frequency and timing of administration with placebo, diet and exercise, and drug treatments.13

Storage

The notifier told the FDA that inositol keeps for 2 years stored sealed in a cool and dry place, a statement about the bulk food ingredient.6 A search found no stability data or leaflet for storage after mixing, or for capsules and tablets.

Side effects reported

A safety review says only the highest myo-inositol dose, 12 g/day, caused mild gastrointestinal side effects, and severity did not rise with dose.14 The Cochrane review in pregnancy reports no maternal adverse effects in the five of its seven studies that reported on this outcome.13

Frequently asked questions

Is a capsule the same as a powder dose?

In a 2012 single-dose study by Carlomagno and colleagues in 20 healthy volunteers, a myo-inositol soft gelatin capsule showed similar pharmacokinetic parameters to three times higher doses of myo-inositol powder.15

References

  1. PubMed. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. 2019. pubmed.ncbi.nlm.nih.gov
  2. PubMed. Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial. 2025. pubmed.ncbi.nlm.nih.gov
  3. PMC. A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women. 2016. pmc.ncbi.nlm.nih.gov
  4. DailyMed. Hormon Balance for Women. 2025. dailymed.nlm.nih.gov
  5. PMC. Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial. pmc.ncbi.nlm.nih.gov
  6. FDA. GRAS-Notice-GRN-1198-Agency-Response-Letter. fda.gov
  7. PubMed. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. 2012. pubmed.ncbi.nlm.nih.gov
  8. PubMed. Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial. 2025. pubmed.ncbi.nlm.nih.gov
  9. ClinicalTrials.gov. NCT05767515: The Effects of Acetyl-L-Carnitine and Myo/Chiro-Inositol in Patients With PCOS. 2024. clinicaltrials.gov
  10. PubMed. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. 1995. pubmed.ncbi.nlm.nih.gov
  11. PubMed. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. 2001. pubmed.ncbi.nlm.nih.gov
  12. PubMed. Inositol treatment of obsessive-compulsive disorder. 1996. pubmed.ncbi.nlm.nih.gov
  13. PMC. Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes. pmc.ncbi.nlm.nih.gov
  14. PubMed. Inositol safety: clinical evidences. 2011. pubmed.ncbi.nlm.nih.gov
  15. PubMed. Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use. 2012. pubmed.ncbi.nlm.nih.gov